NAD+ Peptide – User Manual & Dosage Protocol Guide

NAD+ (Nicotinamide Adenine Dinucleotide) Peptide is a research-grade compound involved in cellular energy production and anti-aging research. It plays a critical role in:

• Supporting cellular metabolism and mitochondrial function
• Enhancing DNA repair and cellular regeneration
• Promoting neuroprotection and cognitive support
• Supporting overall anti-aging and cellular vitality

Disclaimer: NAD+ peptide is for research and experimental use only. It is not FDA-approved for therapeutic use. Consult a qualified healthcare professional before use.

Lyophilized Powder

• Description: Freeze-dried NAD+ peptide for reconstitution

Injection Solution

• Description: Subcutaneous (SC) or intravenous (IV) solution after reconstitution

Oral Capsules

• Description: Experimental use; bioavailability may be limited
  

NAD+ peptide works by:

• Serving as a coenzyme in redox reactions, crucial for ATP production
• Supporting mitochondrial health and energy metabolism
• Promoting DNA repair and genomic stability
• Acting as a cofactor for sirtuin activation, associated with longevity

Effects are primarily observed in research studies and experimental protocols.

Administration

Subcutaneous (SC) Injection – Typical Dose: 5–20 mg | Frequency: 2–3× per week | Notes: Used for general cellular support in research settings

Intravenous (IV) Injection – Typical Dose: 10–50 mg | Frequency: 1–2× per week | Notes: Rapid systemic effect; often administered slowly under supervision

Oral Capsules – Typical Dose: 250–500 mg | Frequency: Daily | Notes: Bioavailability is lower than injection; effects are slower

Cycle Protocol (Investigational)

Initial Phase (1–2 weeks) – Dose: Lower end of dosing range | Notes: Monitor tolerance and response

Therapeutic Phase (4–6 weeks) – Dose: Full dose range | Notes: Maximum cellular and metabolic support

Rest Period (1–2 months) – Dose: None | Notes: Allows the system to reset before next cycle

Experimental cycles are often repeated 2–4 times per year, depending on study objectives.

Supplies Needed: Sterile bacteriostatic water | Sterile syringe | Alcohol swabs

Steps:

1. Clean vial top with alcohol swab.
2. Add the desired volume of bacteriostatic water (e.g., 10 mg peptide + 2 mL water → 5 mg/mL solution).
3. Swirl gently to dissolve; do not shake.
4. Store refrigerated (2–8°C).
5. Use within 2–4 weeks; discard if cloudy or discolored.

Subcutaneous Injection (SC)

1. Select a clean injection site (abdomen, thigh, or upper arm).
2. Clean with alcohol swab.
3. Insert needle at 45° angle.
4. Inject slowly and steadily.
5. Apply gentle pressure; rotate injection sites weekly.

Intravenous Injection (IV)

• Administer slowly via trained personnel.
• Ensure sterile technique and proper dilution.
• Monitor subjects for adverse reactions.

Oral Capsules

• Take on an empty stomach for better absorption.
• Daily consistent dosing is recommended.

Storage InformationLyophilized Powder – Storage: Cool, dry place | Shelf Life: Up to 12 months

Reconstituted Solution – Storage: Refrigerate 2–8°C | Shelf Life: 2–4 weeks

Oral Capsules – Storage: Room temperature, dry place | Shelf Life: 12 months

Discard solution if cloudy, discolored, or contains particulates.

• Not recommended for pregnant or breastfeeding women
• Avoid if allergic to peptides
• Mild side effects may include irritation at injection site or mild nausea
• Discontinue if severe adverse reactions occur
• Keep out of reach of children

Human clinical data are limited; all effects are investigational.

Weekly Cycle ScheduleWeek 1–2 – Dose: 5–10 mg SC/IV, 2× per week | Notes: Initial tolerance phase

Week 3–4 – Dose: 10–20 mg SC/IV, 2–3× per week | Notes: Therapeutic dose

Week 5–6 – Dose: 20 mg SC/IV, 2–3× per week | Notes: Full therapeutic cycle

Week 7+ – Dose: Rest | Notes: 1–2 month break before next cycle

• Diagrams of SC and IV injection sites (abdomen, thigh, arm, forearm)
• Step-by-step reconstitution guide
• Safety icons for handling, storage, and injections